1. Home
  2. ASMB vs LEE Comparison

ASMB vs LEE Comparison

Compare ASMB & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • LEE
  • Stock Information
  • Founded
  • ASMB 2005
  • LEE 1890
  • Country
  • ASMB United States
  • LEE United States
  • Employees
  • ASMB N/A
  • LEE N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • ASMB Health Care
  • LEE Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • LEE Nasdaq
  • Market Cap
  • ASMB 84.5M
  • LEE 90.6M
  • IPO Year
  • ASMB 2010
  • LEE N/A
  • Fundamental
  • Price
  • ASMB $13.02
  • LEE $11.46
  • Analyst Decision
  • ASMB Buy
  • LEE
  • Analyst Count
  • ASMB 2
  • LEE 0
  • Target Price
  • ASMB $35.00
  • LEE N/A
  • AVG Volume (30 Days)
  • ASMB 22.1K
  • LEE 23.1K
  • Earning Date
  • ASMB 03-27-2025
  • LEE 02-06-2025
  • Dividend Yield
  • ASMB N/A
  • LEE N/A
  • EPS Growth
  • ASMB N/A
  • LEE N/A
  • EPS
  • ASMB N/A
  • LEE N/A
  • Revenue
  • ASMB $28,326,000.00
  • LEE $600,264,000.00
  • Revenue This Year
  • ASMB $282.16
  • LEE N/A
  • Revenue Next Year
  • ASMB N/A
  • LEE N/A
  • P/E Ratio
  • ASMB N/A
  • LEE N/A
  • Revenue Growth
  • ASMB N/A
  • LEE N/A
  • 52 Week Low
  • ASMB $11.05
  • LEE $7.57
  • 52 Week High
  • ASMB $19.93
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.89
  • LEE 32.32
  • Support Level
  • ASMB $12.10
  • LEE $11.40
  • Resistance Level
  • ASMB $14.25
  • LEE $13.69
  • Average True Range (ATR)
  • ASMB 0.60
  • LEE 0.80
  • MACD
  • ASMB -0.10
  • LEE -0.10
  • Stochastic Oscillator
  • ASMB 35.11
  • LEE 6.58

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: